Literature DB >> 953

Characterization of an extracellular dextranase from Fusarium moniliforme.

L G Simonson, A E Liberta, A Richardson.   

Abstract

An extracellular dextranase (EC 3.2.1.11) was purified approximately 75-fold from cell-free culture filtrates of Fusarium moniliforme. The purified dextranase was of the endo type, and isomaltose was identified as the primary end product of dextran hydrolysis. The molecular weight of the dextranase was determined to be 39,000 by gel permeation chromatography. The enzyme was most active at pH 5.5, and the temperature optimum was near 55 C. Activity was not inhibited by either ethylenediaminetetraacetic acid or iodoacetate. The Km for dextran with an average molecular weight of 10,000 was estimated to be 1.1 X 10(-4) M. The electrophoretic mobility of the dextranase was distinctly different from that of a Penicillium-derived commercial dextranase. The F. moniliforme dextranase was also found to differ from the commercial preparation by its greater relative activity against glucans isolated from Streptococcus mutans.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 953      PMCID: PMC187284          DOI: 10.1128/am.30.5.855-861.1975

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  21 in total

1.  Dextran-degrading enzymes from molds.

Authors:  H M TSUCHIYA; A JEANES; H M BRICKER; C A WILHAM
Journal:  J Bacteriol       Date:  1952-10       Impact factor: 3.490

2.  Enzymes of starch degradation and synthesis.

Authors:  P BERNFELD
Journal:  Adv Enzymol Relat Subj Biochem       Date:  1951

3.  Detection of sugars on paper chromatograms.

Authors:  W E TREVELYAN; D P PROCTER; J S HARRISON
Journal:  Nature       Date:  1950-09-09       Impact factor: 49.962

4.  A procedure for rapid and sensitive staining of protein fractionated by polyacrylamide gel electrophoresis.

Authors:  A Chrambach; R A Reisfeld; M Wyckoff; J Zaccari
Journal:  Anal Biochem       Date:  1967-07       Impact factor: 3.365

5.  Studies on dextranase. Purification of dextranase from Penicillium funiculosum and its enzymatic properties.

Authors:  M Sugiura; A Ito; T Ogiso; K Kato; H Asano
Journal:  Biochim Biophys Acta       Date:  1973-06-06

6.  Formation and significance of bacterial polysaccharides in caries etiology.

Authors:  R J Gibbons
Journal:  Caries Res       Date:  1968       Impact factor: 4.056

7.  Morphological study of Streptococcus mutans and two extracellular polysaccharide mutants.

Authors:  M C Johnson; J J Bozzola; I L Shechmeister
Journal:  J Bacteriol       Date:  1974-04       Impact factor: 3.490

8.  Diminished virulence of glucan synthesis-defective mutants of Streptococcus mutans.

Authors:  J M Tanzer; M L Freedman; R J Fitzgerald; R H Larson
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

9.  Dissociation of plaque formation from glucan-induced agglutination in mutants of Streptococcus mutans.

Authors:  M L Freedman; J M Tanzer
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

10.  Estimation of the molecular weights of proteins by Sephadex gel-filtration.

Authors:  P Andrews
Journal:  Biochem J       Date:  1964-05       Impact factor: 3.766

View more
  4 in total

Review 1.  Biology, immunology, and cariogenicity of Streptococcus mutans.

Authors:  S Hamada; H D Slade
Journal:  Microbiol Rev       Date:  1980-06

2.  Effects of dextranases on attachment of Streptococcus mutans to hydroxyapatite.

Authors:  L G Simonson; D Jackola
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

3.  Application of statistical design for the optimization of dextranase production by a novel fungus isolated from Red Sea sponge.

Authors:  Nayera A M Abdelwahed; Eman Fadl Ahmed; Eman W El-Gammal; Usama W Hawas
Journal:  3 Biotech       Date:  2013-12-17       Impact factor: 2.406

4.  Purification and Characterization of a Biofilm-Degradable Dextranase from a Marine Bacterium.

Authors:  Wei Ren; Ruanhong Cai; Wanli Yan; Mingsheng Lyu; Yaowei Fang; Shujun Wang
Journal:  Mar Drugs       Date:  2018-02-07       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.